Head-To-Head Comparison: Claritev (NYSE:CTEV) & OneMedNet (NASDAQ:ONMD)

Claritev (NYSE:CTEV) and OneMedNet (NASDAQ:ONMD) are both small-cap healthcare companies, but which is the superior business? We will contrast the two companies based on the strength of their valuation, analyst recommendations, profitability, risk, earnings, dividends and institutional ownership.

Valuation & Earnings

This table compares Claritev and OneMedNet”s gross revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Claritev	$965.41 million	0.48	-$284.28 million	($16.42)	-1.65
OneMedNet	$1.36 million	23.33	-$2.80 million	($1.60)	-3.34

OneMedNet has lower revenue, but higher earnings than Claritev. OneMedNet is trading at a lower price-to-earnings ratio than Claritev, indicating that it is currently the more affordable of the two stocks.

Institutional and Insider Ownership

87.2% of Claritev shares are held by institutional investors. Comparatively, 0.9% of OneMedNet shares are held by institutional investors. 7.4% of Claritev shares are held by company insiders. Comparatively, 50.2% of OneMedNet shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Profitability

This table compares Claritev and OneMedNet’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Claritev	-27.05%	N/A	-5.74%
OneMedNet	-584.20%	N/A	-521.20%

Volatility and Risk

Claritev has a beta of 1.05, indicating that its stock price is 5% more volatile than the S&P 500. Comparatively, OneMedNet has a beta of 1.25, indicating that its stock price is 25% more volatile than the S&P 500.

Analyst Ratings

This is a breakdown of current recommendations for Claritev and OneMedNet, as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Claritev	1	2	6	0	2.56
OneMedNet	1	0	0	0	1.00

Claritev presently has a consensus price target of $44.83, indicating a potential upside of 65.38%. Given Claritev’s stronger consensus rating and higher probable upside, research analysts clearly believe Claritev is more favorable than OneMedNet.

Summary

Claritev beats OneMedNet on 8 of the 13 factors compared between the two stocks.

About Claritev

Claritev, formerly known as MultiPlan, provides technology-enabled services intended to help manage healthcare costs and support payment accuracy. Its offerings include access to provider networks, claims and payment solutions, and data analytics for evaluating healthcare costs and utilization. The company serves health plans, self-insured employers, third-party administrators and other participants in the U.S. healthcare system. Its services are designed to help customers identify cost-management opportunities and support more efficient healthcare transactions.

About OneMedNet

OneMedNet Corporation (NASDAQ: ONMD) is a healthcare technology company focused on improving the access, exchange and use of medical imaging data. Its platform is designed to connect healthcare organizations, researchers, life sciences companies and other authorized users with clinical imaging datasets while supporting data privacy, security and governance requirements. OneMedNet’s technology uses a decentralized approach in which medical data can remain with the organization that originally collected it, rather than being transferred to a central repository.